Olive Hits $4 Billion Valuation With Latest Funding Round

San Francisco – July 9, 2021 – Cooley advised digital health automation company Olive on its $400 million funding round, which brings its valuation to $4 billion. Lawyers Peter Werner and Melissa Boyd led the Cooley team advising Olive.

Vista Equity Partners and Base10 Partners’ Advancement Initiative led the round, which also included participation from existing investor Tiger Global Management. Olive will use the new funding to develop more products and hire additional employees, with a goal of more than doubling its 800-person workforce this year.

“We’ve talked about the trillion dollars of waste in healthcare – our goal is to shift those resources to other areas,” Sean Lane, CEO of Olive, said in a news release. “We’re looking into global expansion and the applicability of our products across the whole planet.”

Olive is addressing healthcare’s most burdensome issues through automation – delivering hospitals, health systems and payers increased revenue, reduced costs and increased capacity. Olive is driving connections to shine new light on healthcare processes, improving operations today so everyone can benefit from a healthier industry tomorrow.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,200 lawyers across 17 offices in the United States, Asia and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.